Table 2.
Results of follow-up at 6 and 12 months
| Variable (n=51) | Median (IQR) | Mean (SD) |
| Health-related quality of life | ||
| EQ-5D, score (0–60) at 6 months | 40 (20) | 41.4 (11.7) |
| EQ-5D, score (0–60) at 12 months | 40 (20) | 39.8 (11.2) |
| EQ-5D VAS (0–100) at 6 months | 60 (30) | 59.9 (22.2) |
| EQ-5D VAS (0–100) at 12 months | 60 (29) | 61.9 (20.8) |
| Participation, RNL-Index (0–100) at 6 months |
65.5 (42) | 64.3 (27.9) |
| Participation, RNL-Index (0–100) at 12 months | 68.2 (53) | 65.9 (27.2) |
| Physical activities, PASIPD (0–100) at 6 months | 7.9 (17.4) | 16.2 (22.4) |
| Physical activities, PASIPD (0–100) at 12 months | 7.9 (17.3) | 12.3 (13.6) |
| Cognitive function | ||
| MoCA (0–30) at 6 months | 24 (5) | 22.8 (5.2) |
| MoCA (0–30) at 12 months | NA | NA |
| CDT (0–6) at 6 months | 1 (1) | 1.7 (1.1) |
| CDT (0–6) at 12 months | 1 (0) | 1.4 (0.8) |
| Pain VAS (0–10) at 6 months | 4 (4) | 4.2 (3.0) |
| Pain VAS (0–10) at 12 months | 3 (6) | 3.5 (3.1) |
CDT, Clock Drawing Test; EQ-5D, health-related quality of life; MoCA, Montreal Cognitive Assessment; NA, not available; PASIPD, Physical Activity Scale for Individuals With Physical Disabilities; RNL-Index, Reintegration of Normal Living Index; VAS, Visual Analogue Scale.